PerkinElmer's Q3 Sales Fall 9 Percent, Bringing Profits Along | GenomeWeb

NEW YORK (GenomeWeb News) – PerkinElmer reported after the close of the market on Thursday that its third-quarter revenues declined around 9 percent and its profit tumbled 57 percent

The Waltham, Mass.-based life sciences company reported total revenues of $437.1 million for the three-month period ended Sept. 30, compared to revenues of $478.7 million for the third quarter of 2008. Currency translation had a negative impact of 2 percent for the quarter, while acquisitions had a positive impact of 1 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In PNAS this week: miR-515 levels higher in women with preeclampsia, horizontal gene transfer in parasitic plants, and more.

A cancer researcher retracts 19 articles from one journal for image manipulation, according to Retraction Watch.

Precision medicine has to consider context in addition to genetic mutations in cancer treatment, Medscape reports.

Genomics may help the Cavendish banana from succumbing to fungal infections, a trio of researchers writes at the Conversation.